Fig 3. Proportion of infection intensities of A. lumbricoides at baseline, 14–21 days, six and 12 months post-treatment in Lao PDR (A) and Pemba Island (B) for ivermectin-albendazole above and albendazole-placebo below.

114 participants in Lao PDR and 127 participants on Pemba Island were initially infected with A. lumbricoides and had a complete data set. Red dashed lines at baseline and follow up represent treatment time points. Abbreviations: BL, baseline assessment; N, number of participants with a complete data set; 3wk, 14–21 days post-treatment follow-up; 6m, 6 months post-treatment follow-up; 1yr, 12 months post-treatment follow-up.